🇮🇳India·Startups·27 May 2026·via The Economic Times
Tata-backed MedTherapy claims CAR-T breakthrough with one-day production
Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can reduce production time from several weeks to just one day and cut costs by nearly 70%, potentially making advanced cancer treatment more affor...
#tata stocks#tata#tata stocks today news#tata shares#tata share price#boston#tata sons#tata memorial hospital#cipla
Original reporting by The Economic TimesWe don't republish, read the full story →
Related reading
6 stories
🇸🇬·Startups
HSBC Gives Wealthy Singapore Clients Access to Private Markets
Startups
OpenAI said to explore pre-IPO funding at $1.2T valuation
🇮🇳·Policy
EU chief to unveil social media, gaming curbs for under-15s
🇮🇳·AI News
OpenAI Backs Bipartisan Bills to Curb AI-Driven Bioweapons
🇰🇷·Startups
Samsung Starts Trial Production of Tesla AI Chips in Texas
🇵ðŸ‡Â·Startups